Randolph E. Regal
University of Michigan
42 Papers
203 Citations
Randolph E. Regal is an academic researcher from University of Michigan. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 17, co-authored 37 publications. Previous affiliations of Randolph E. Regal include Parke-Davis & American Pharmacists Association.
Chat about Author
Papers
Impact of a pharmacist-facilitated hospital discharge program: a quasi-experimental study.
Paul C. Walker,Steven J. Bernstein,Jasmine N. Tucker Jones,John Piersma,Hae Won Kim,Randolph E. Regal,Latoya Kuhn,Scott A. Flanders +7 more
TL;DR: While the intervention improved the quality of patient discharge by identifying and reconciling medication discrepancies at discharge, there was no effect on postdischarge health care resource utilization.
257
Acid Suppressive Therapy Use on an Inpatient Internal Medicine Service
TL;DR: There is considerable excess usage of acid suppressants in both the inpatient and outpatient settings, particularly in patients with any history of gastroesophageal reflux disorder.
153
Incidence of Carbapenem-Associated Allergic-Type Reactions among Patients with versus Patients without a Reported Penicillin Allergy
TL;DR: No difference in the occurrence of allergic-type reactions was observed between the 2 carbapenems, and whether the incidence of cross-reactivity is different between imipenem-cilastatin and meropenem was sought.
90
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study
Jeffrey A. Berinstein,Jessica L. Sheehan,Michael Dias,Elliot M. Berinstein,Calen A. Steiner,Laura A. Johnson,Randolph E. Regal,John I. Allen,Kelly C. Cushing,Ryan W. Stidham,Shrinivas Bishu,Jami Kinnucan,Shirley Cohen-Mekelburg,Akbar K. Waljee,Peter D.R. Higgins +14 more
TL;DR: Tofacitinib is a rapidly acting Janus kinase inhibitor with proven efficacy in ulcerative colitis and may provide additional means for preventing colectomy in patients with ASUC.
82